Myeloma Today Spring 2008 Volume 7 Issue 6

Dear Reader

Board of Directors: Myeloma Today in conversation with Mark DiCicilia
Scientific Advisory Board: Myeloma Today in conversation with Dr. Alan Solomon
News & Notes
Scientific & Clinical: Europe Update: Frontline Myeloma Therapy; Myeloma Today in conversation with Dr. Jesus San Miguel
Scientific & Clinical: Clinical Trials Update; Myeloma Today in conversation with Dr. Keith Stewart
Scientific & Clinical: Bank On A Cure® Research Initiative Update; Myeloma Today in conversation with Dr. Brian Durie
Scientific & Clinical: Curcumin in Multiple Myeloma; Myeloma Today in conversation with Dr. Bharat Aggarwal
Special Event: Prof. Mario Boccadoro Receives the Robert A. Kyle Lifetime Achievement Award
Supportive Care: IMF Hotline Coordinators Answer Your Questions: "My doctor has just prescribed Revlimid® (lenalidomide) and dexamethasone, and I’ve read that blood clots can be caused by this regimen. What can I do to guard against this?"
Nurse Leadership Board: Report from 2008 NLB Meeting
Education and Awareness: Spotlight on Advocacy; President Bush Includes Slight Increase for Cancer Research Funding
Education and Awareness: Cancer Awareness Day, First St. Louis Regional Community Workshop a Great Success!, BlueVoice.org Conducting Toxins Testing Program
Education and Awareness: Did You Know?
International Affliates: Updates from Japan and Latin America
Support Group Profiles:

 

  • East Texas Myeloma Support Group
  • Tampa/St. Petersburg Myeloma Support Group

Patient and Caregiver Experience: Christine McClay - My Many Miracles
Member Events: IMFers Raise Funds to Benefit Myeloma Community

  • Jammin’ For A Cause
  • Mailing For A Cure

Investing in the Future: Myeloma Today in conversation with David Brown
Planned Giving
Cell Phones For A Cure
2008 IMF Calendar of Events

Letters to the IMF

Click here to download Myeloma Today

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.